期刊文献+

甲状腺微小癌Ⅵ区淋巴结转移相关因素研究 被引量:6

Factors Related to Metastasis of Central Compartment Lymph Nodes(Level Ⅵ) in Patients with Papillary Thyroid Microcarcinoma
原文传递
导出
摘要 目的探讨临床颈侧区淋巴结阴性(cN0)甲状腺乳头状微小癌(PTMC)中央区淋巴结转移相关的临床病理因素。方法回顾分析2007年1月-2010年1月初治的109例颈侧区cN0 PTMC患者的资料,探讨与PTMCⅥ区淋巴结转移相关的临床病理因素。结果 109例PTMC患者中Ⅵ区淋巴结转移率为31.2%(34/109)。单因素分析发现肿瘤最大径(≥5 mm)、多发病灶与PTMCⅥ区淋巴结转移显著相关(P<0.05);Logistic回归模型多因素分析显示肿瘤最大径(≥5 mm)、多发病灶为PTMCⅥ区淋巴结转移的独立危险因素(P<0.05)。结论 PTMC中原发灶大小(≥5 mm)、多发病灶患者Ⅵ区淋巴结转移率显著升高。对于这两类PTMC患者需常规行Ⅵ区淋巴结清扫。 Objective To analyze the related elinicopathologic factors of central compartment lymph node metastasis( CCLNM ) in clinically node negative neck(cN0) patients with thepapillary thyroid microcarcinoma( PTMC ). Methods The clinical data of one hundred and nine( 21 males and 88 female) eN0 patients with FFMC undergoing the thyroid lobectomy or total thyroideeto- my and central compartment lymph node dissection from Jan. 2007 to Jan. 2010 were analyzed retrospectively. The clinicopathologic factors which related to CCLNM,such as age,sex, tumor size, tumor capsule, multifocality and mierocalcification,were analyzed. Results CCLNM was found in 34 of the 109 patients (31.2% ). Tumor size ( ≥ 5 mm) , muhifocality were found signifi- cantly related to CCLNM metastasis in univariate analysis ( P 〈 0.05 ). The multivariate linear regression analysis showed that tumor size( ≥ 5 ram) and muhifocality were the independent risk factors (P 〈 0.05 ). Conclusion CCLNM occurs more frequently in the PTMC patients with Tumor size(≥5 mm) and muhifocality. The routine ipsilateral level VI lymph node dissection should be performed in patients with those risk factors.
出处 《中华全科医学》 2011年第9期1350-1350,1419,共2页 Chinese Journal of General Practice
关键词 甲状腺肿瘤 淋巴结转移 甲状腺乳头状微小癌 Thyroid neoplasm Lymph node metastasis Papillary thyroid microcarcinoma
  • 相关文献

参考文献11

  • 1Lloyd R, DeLellis R, Heitz P, et al. World Health Organization Classifi- cation of Tumours : Pathology and Genetics of Tumours of the Endocrine Organs [ M ]. Lyon, France: IARC Press International Agency for Re- search on Cancer,2004.
  • 2IanD. Hay, Maeve E, TomasGonzalez-Losada, et al. Papillary thyroid microcarcinoma:A study of 900 cases observed in a 60-year period [ J]. Surgery ,2008,144:980-988.
  • 3Shiro Noguchi, Hiroto Yamashita, Shinya Uchino, et al. Papillary Mi- crocarcinoma[ J]. World J Surg,2008 ,32 :747-753.
  • 4Sin-MingChow, StephenC. K. Law, JohnK. C. Chan, et al. Papillary Mi- crocarcinoma of the Thyroid Prognostic Signicance of Lymph Node Me- tastasis and Muhifocality [ J ]. Cancer,2003,98:31-40.
  • 5邵雁,蔡秀军,高力,李华,谢磊.甲状腺微小乳头状癌中央区淋巴结转移及临床因素分析[J].中华医学杂志,2009,89(6):403-405. 被引量:33
  • 6王宇,嵇庆海,黄彩平,朱永学,张凌.甲状腺乳头状微癌Ⅵ区淋巴结转移相关因素分析[J].中华外科杂志,2008,46(24):1899-1901. 被引量:10
  • 7林益凯,盛建明,赵文和,王伟斌,俞雄飞,滕理送,马志敏.多灶性甲状腺乳头状癌168例临床研究[J].中华外科杂志,2009,47(6):450-453. 被引量:41
  • 8Dong-JunLim, Ki-HyunBaek, Youn-SooLee, et al. Clinical, Histopatho- logical,and Molecular Characteristics of Papillary Thyroid Microcarci- noma [ J ]. THYROID,2007,17 (9) :883-888.
  • 9Xiaoqi Lin, SD Finkelstein, Bing Zhu, et al. Molecular analysis of mul- tifocal papillary thyroid carcinoma [ J ]. Journal of Molecular Endocri- nology, 2008,41:195-203.
  • 10Jen-Der Lin, Tzu-Chieh Chao, Chuen Hsueh, et al. High Recurrent Rate of Multicentric PapillaryThyroid Carcinoma [ J ]. Ann Surg On- col, 2009,16:2609 -2616.

二级参考文献29

共引文献77

同被引文献64

  • 1田丰秋,吕丽,冯晓海,王乃玉,张文波,王莉芬.甲状腺乳头状癌的诊断及转移相关的免疫组化研究[J].中华肿瘤防治杂志,2007,14(13):986-988. 被引量:5
  • 2Hedinger C, Williams ED, Sobin LH. The WHO histological clas- sification of thyroid tumors: a commentary on the second edition [I]. Cancer, 1989, 63(5):908-911.
  • 3Yamamoto Y, Maeda T, Izumi K, et al. Occult papillary carcino- ma of the thyroid. A study of 408 autopsy eases [ J ]. Cancer, 1990, 65(5) : 1173-1179.
  • 4Lin KD, Lin JD, Huang HS, et al. Skull metastasis with brain in- vasion from thyroid papillary rnierocarcinoma [ J ]. J Formos Med Assoe, 1997, 96(4) : 280-282.
  • 5Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thy- roid mieroeareinoma: a study of 900 eases observed in a 60-year period[J]. Surgery, 2008, 144(6) : 980-988.
  • 6Qubain SW, Nakano S, Baba M, et al. Distribution of lymph node mierometastasis in pN0 well-differentiated thyroid carcinoma [ J ]. Surgery, 2002, 131 (3): 249-256.
  • 7Leenhardt L, Grosclaude P, Cherie-Challine L, et al. Increased incidence of thyroid carcinoma in France: a true epidemic or thy- roid nodule management effects? Report from the French thyroid cancer Conunittee [ l ]. Thyroid, 2004, 14 ( 12 ) : 1056-1060.
  • 8Xiang J, Wu Y, Li DS, et al. New clinical features of thyroid canc- er in eastern China[J]. J Vise Surg, 2010, 147(1): e53-e56.
  • 9Goropoulos A, Karamoshos K, Christodoulou A, et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma [ J ]. World J Surg, 2004, 28 ( 12 ) : 1275-1281.
  • 10Shaha AR. Management of the neck in thyroid cancer[ J ].Otolar- yngol Clin North Am, 1998, 31 (5) : 823-831.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部